Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060649/0360 | |
| Pages: | 6 |
| | Recorded: | 07/13/2022 | | |
| Attorney Dkt #: | 048440-734P01US/734001WO |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE OMISSION SECOND ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 059327 FRAME: 0691. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17767398
|
Filing Dt:
|
04/07/2022
|
|
Publication #:
|
|
Pub Dt:
|
03/21/2024
| | |
PCT #:
|
US2055102
|
|
Title:
|
CANCER COMBINATION TREATMENTS USING ANTI-STAT3 NUCLEIC ACID CONJUGATES
|
|
|
Assignee
|
|
|
|
|
| 1500 E. DUARTE ROAD |
| DUARTE, CALIFORNIA 91010 |
|
|
Correspondence name and address
|
| |
MINTZ LEVIN
|
| |
ONE FINANCIAL CENTER
|
| |
BOSTON, MA 02111
|
Search Results as of:
05/07/2024 03:06 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
